NCT05774951 · Interventional trial
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Overall registry status Recruiting
Phase 3
Conditions Breast Cancer, Early Breast Cancer
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County · Active not recruiting
- Research Site · Philadelphia, PA · Philadelphia County · Active not recruiting
First posted
Registry updated
Added to the directory